Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Leerink 2025 Global Healthcare Conference March 10, 2025 9:20 AM ETCompany ParticipantsLucas Montarce - CFOMike Czapar ...
Micheál Martin may need to pledge some material incentives to increase the size of Irish business investors in the US ...
Eli Lilly is playing its part in helping conserve local wildlife with the relocation of a rare meadow barley species on its ...
Eli Lilly is investing $27 billion in U.S. manufacturing to expand drug production and secure future supply. The company will ...
THE RESULTS of Limerick city’s air quality are in, with the campaign labelled as “a great success story”. In October 2024, ...
Digital Manufacturing Ireland (DMI) is excited to announce the launch of the Vision Accelerator at its headquarters in ...
Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...
Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...
The news comes amid the possibility that President Trump imposes a 25% tariff on pharmaceuticals, which could encourage manufacturers to begin reshoring their services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results